KMT2A and acute lymphoblastic leukemia: The main oncogenic hit of MLL‐rearranged ALL is the in‐frame fusion of the MLL gene with one of multiple fusion partner genes, generating MLL fusion genes that encode chimeric proteins that drive leukemogenicity and disease maintenance [4, 5, 6].